Optimization of an Experimental Vaccine To Prevent Escherichia

Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs: Trends in Pharmacological Sciences

PDF) Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection

Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics

Memory B cell diversity: insights for optimized vaccine design: Trends in Immunology

Recent Advances in Multifunctional Microneedle Patches for Wound Healing and Health Monitoring - Pan - 2023 - Advanced NanoBiomed Research - Wiley Online Library

Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments

A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens

Vaccine-induced COVID-19 mimicry syndrome

Media optimization for SHuffle T7 Escherichia coli expressing SUMO-Lispro proinsulin by response surface methodology, BMC Biotechnology

Enhancing Patient Outcomes with Advanced PCR and ABR Testing: A Total Lab Solutions Advantage

Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting - ScienceDirect

Frontiers Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications

Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice